2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by BARICOS, W. H. Articles by XIN, S. Search for Related Content PubMed PubMed Citation Articles by BARICOS, W. H. Articles by XIN, S.

Transforming Growth Factor-ß Is a Potent Inhibitor of Extracellular Matrix Degradation by Cultured Human Mesangial Cells

Department of Biochemistry, Tulane Medical School, New Orleans, Louisiana.

Correspondence to Dr. William H. Baricos, Department of Biochemistry, SL-43, Tulane Medical School, 1430 Tulane Avenue, New Orleans, LA 70112. Phone: 504-584-2452; Fax: 504-584-2739; E-mail: baricosw{at}mailhost.tcs.tulane.edu

Abstract. Accumulation of the glomerular extracellular matrix (ECM) is a pivotal event in the progression from acute glomerular injury to end-stage renal disease. Although enhanced ECM synthesis has been demonstrated to contribute to ECM accumulation, the role of decreased ECM degradation is largely unknown. It was previously shown that glomerular ECM degradation is mediated by a plasminogen activator (PA)/plasmin/matrix metalloproteinase 2 (MMP-2) cascade. However, little information is available regarding the factors that regulate the activity of this degradative cascade in normal or pathologic states. Transforming growth factor-ß1 (TGF-ß1) is shown here to be a potent inhibitor of ECM degradation by cultured human mesangial cells. Using human mesangial cells grown on thin films of ¹²⁵I-labeled Matrigel, dose-dependent inhibition of ECM degradation in the presence of TGF-ß1 was observed, reaching >90% inhibition with 0.4 ng/ml TGF-ß1. Addition of anti-TGF-ß antibodies (4 µg/ml) in the absence of exogenous TGF-ß increased ECM degradation (1.8 ± 0.2-fold versus controls, P < 0.05). In contrast, platelet-derived growth factor, at concentrations up to 10 ng/ml, had no effect on ECM degradation. TGF-ß completely blocked the conversion of plasminogen to plasmin and markedly reduced the conversion of latent MMP-2 to active MMP-2. TGF-ß did not significantly alter the levels of tissue PA, total MMP-2, or tissue inhibitor of metalloproteinase-1, but did increase the levels of PA inhibitor-1 (1.8-fold, P < 0.05), the major physiologic inhibitor of PA. These data document that TGF-ß is a potent inhibitor of ECM degradation by cultured human mesangial cells, and they suggest that decreased mesangial matrix degradation, caused by TGF-ß-mediated decreases in the activity of the PA/plasmin/MMP-2 cascade, may contribute to the glomerular matrix accumulation that occurs in progressive renal disease.

This article has been cited by other articles:

				J. Floege, F. Eitner, and C. E. Alpers A New Look at Platelet-Derived Growth Factor in Renal Disease J. Am. Soc. Nephrol., January 1, 2008; 19(1): 12 - 23. [Abstract] [Full Text] [PDF]

				Jun Yuan, Ruhan Jia, and Yan Bao Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats Journal of Renin-Angiotensin-Aldosterone System, September 1, 2007; 8(3): 118 - 126. [Abstract] [PDF]

				Y.-C. Tian, Y.-C. Chen, C.-C. Hung, C.-T. Chang, M.-S. Wu, A. O. Phillips, and C.-W. Yang Leptospiral Outer Membrane Protein Induces Extracellular Matrix Accumulation through a TGF-beta1/Smad-Dependent Pathway J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2792 - 2798. [Abstract] [Full Text] [PDF]

				S. Y. Han, Y. H. Jee, K. H. Han, Y. S. Kang, H. K. Kim, J. Y. Han, Y. S. Kim, and D. R. Cha An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2406 - 2416. [Abstract] [Full Text] [PDF]

				E. Sugaru, T. Nakagawa, M. Ono-Kishino, J. Nagamine, T. Tokunaga, M. Kitoh, W. E. Hume, R. Nagata, and M. Taiji SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice Am J Physiol Renal Physiol, April 1, 2006; 290(4): F813 - F820. [Abstract] [Full Text] [PDF]

				L. Xia, H. Wang, H. J. Goldberg, S. Munk, I. G. Fantus, and C. I. Whiteside Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression Am J Physiol Renal Physiol, February 1, 2006; 290(2): F345 - F356. [Abstract] [Full Text] [PDF]

				S L Ho, G F Dogar, J Wang, J Crean, Q D Wu, N Oliver, S Weitz, A Murray, P E Cleary, and C O'Brien Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome Br. J. Ophthalmol., February 1, 2005; 89(2): 169 - 173. [Abstract] [Full Text] [PDF]

				R. Gong, A. Rifai, E. M. Tolbert, J. N. Centracchio, and L. D. Dworkin Hepatocyte Growth Factor Modulates Matrix Metalloproteinases and Plasminogen Activator/Plasmin Proteolytic Pathways in Progressive Renal Interstitial Fibrosis J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3047 - 3060. [Abstract] [Full Text] [PDF]

				W. H. Baricos, J. C. Reed, and S. L. Cortez Extracellular Matrix Degradation by Cultured Mesangial Cells: Mediators and Modulators Experimental Biology and Medicine, October 1, 2003; 228(9): 1018 - 1022. [Abstract] [Full Text] [PDF]

				H. B. Lee, M.-R. Yu, Y. Yang, Z. Jiang, and H. Ha Reactive Oxygen Species-Regulated Signaling Pathways in Diabetic Nephropathy J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S241 - 245. [Abstract] [Full Text] [PDF]

				H. Ha and H. B. Lee Reactive Oxygen Species and Matrix Remodeling in Diabetic Kidney J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S246 - 249. [Abstract] [Full Text] [PDF]

				S. Wang and R. Hirschberg BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells Am J Physiol Renal Physiol, May 1, 2003; 284(5): F1006 - F1013. [Abstract] [Full Text] [PDF]

				H. W. Schnaper, T. Hayashida, S. C. Hubchak, and A.-C. Poncelet TGF-beta signal transduction and mesangial cell fibrogenesis Am J Physiol Renal Physiol, February 1, 2003; 284(2): F243 - F252. [Abstract] [Full Text] [PDF]

				A. A. Eddy Plasminogen activator inhibitor-1 and the kidney Am J Physiol Renal Physiol, August 1, 2002; 283(2): F209 - F220. [Abstract] [Full Text] [PDF]

				J. Yao, T. Morioka, B. Li, and T. Oite Endothelin is a potent inhibitor of matrix metalloproteinase-2 secretion and activation in rat mesangial cells Am J Physiol Renal Physiol, April 1, 2001; 280(4): F628 - F635. [Abstract] [Full Text] [PDF]

				S. M Wileman, N. A Booth, N. Moore, B. Redmill, J. V Forrester, and R. M Knott Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells Br. J. Ophthalmol., April 1, 2000; 84(4): 417 - 422. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673